Add BrightSurf on Google Email

Two previously unknown bacterial species identified from patients with inflammatory bowel disease

Researchers have isolated two new bacterial species from patients with inflammatory bowel disease (IBD), which break down the protective mucus layer of the gut. The bacteria, Allobaculum mucilyticum and Allobaculum fili, are highly efficient at degrading intestinal mucus, leading to potent immune responses.

SourceUniversity Medical Center Utrecht·JournalINTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY·TypeExperimental study·DateJan 12, 2023

Move over, mice: caterpillars could replace some mammals in the study of human disease

Scientists have found that caterpillars can be used as an alternative to rodent models for studying gut inflammation, a risk factor for colorectal cancer. The tobacco hornworm caterpillar has a high degree of similarity to the human gut structure and physiology, making it a promising model organism for future research.

SourceMemorial Sloan Kettering Cancer Center·JournalNature Communications·TypeExperimental study·DateJan 12, 2023

New study puts gut microbiome at the center of Parkinson’s disease pathogenesis

A recent study published in Nature Communications has found a significant imbalance in the gut microbiome of individuals with Parkinson's disease. The researchers discovered that over 30% of micro-organisms and bacterial genes tested had altered abundances, indicating a widespread imbalance in the microbiome.

SourceUniversity of Alabama at Birmingham·JournalNature Communications·TypeData/statistical analysis·DateJan 10, 2023

Eating almonds daily boosts exercise recovery molecule by 69% among ‘weekend warriors’

A randomized controlled trial found that daily almond supplementation increased the beneficial fat molecule 12,13-DiHOME in blood plasma after intense exercise. This increase was associated with reduced muscle damage and fatigue, as well as improved recovery from exercise. The researchers suggest that polyphenols in almond skin may be ...

SourceFrontiers·JournalFrontiers in Nutrition·TypeRandomized controlled/clinical trial·DateJan 9, 2023

Inflammatory trigger a new clue in Alzheimer’s

Researchers at UT Health San Antonio identified a new inflammatory trigger in Alzheimer's disease and progressive supranuclear palsy, involving 'jumping genes' that form double-stranded RNA mimicking viral infections. This discovery opens new doors for understanding astrocyte biology and their role in transposable element control.

SourceUniversity of Texas Health Science Center at San Antonio·JournalScience Advances·TypeExperimental study·DateJan 6, 2023

University of Cincinnati research shows people with latent tuberculosis infection are more prone to inflammation

Researchers at the University of Cincinnati found a link between latent tuberculosis infection and increased inflammation in monocytes, a type of white blood cell. This connection may contribute to a higher risk of cardiovascular disease in individuals with LTBI.

SourceUniversity of Cincinnati·JournalOpen Forum Infectious Diseases·TypeRandomized controlled/clinical trial·DateJan 6, 2023

UNC health provider ushers in first FDA-approved medication for eosinophilic esophagitis

Dupilumab, an FDA-approved medication, offers new hope for patients with eosinophilic esophagitis, a rising condition in the US. The treatment reduces eosinophil counts and improves symptoms of dysphagia, leading to better endoscopic healing and histologic severity improvements.

SourceUniversity of North Carolina Health Care·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateDec 21, 2022

Genes & Cancer | Systems biology network reveals the correlation between COX-2 expression and Ch 7q copy number alterations in Ch 11q-deleted pediatric neuroblastoma tumors

Researchers analyzed COX-2 levels and segmental chromosome aberrations in pediatric neuroblastoma tumor samples. Positive correlations between pre-CT Ch 7q gain and COX-2 expression were found, as well as negative correlations between Ch 7q gain and Ch 11q deletion.

SourceImpact Journals LLC·JournalGenes & Cancer·TypeData/statistical analysis·DateDec 16, 2022

Olfactory viral inflammation associated with accelerated onset of Alzheimer's disease

A new study suggests that olfactory viral inflammation may accelerate the onset of Alzheimer's disease by disrupting connections between the sense of smell and memory centers. Researchers found altered myelination in the olfactory tract, leading to inflammation in the hippocampus, which controls memory and learning.

SourceUniversity of Colorado Anschutz Medical Campus·JournalNeurobiology of Aging·TypeExperimental study·DateDec 14, 2022

Scientists reveal the role of immune progenitor cells in the repair of inflamed intestinal tissue

Researchers from Kumamoto University reveal how hematopoietic stem and progenitor cells orchestrate intestinal tissue repair through microbial signals. The study found that acute gut inflammation triggers the activation and expansion of immune progenitor cells, which migrate to lymph nodes to promote tissue repair.

SourceKumamoto University·JournalThe EMBO Journal·TypeExperimental study·DateDec 8, 2022

UCalgary study points to potential new treatment for inflammatory bowel diseases

Researchers at UCalgary have discovered a potential new treatment for fibrosis, a condition that causes thickening of the gut wall and life-threatening blockage in people with Crohn's disease and ulcerative colitis. The study suggests that drugs targeting specific sensors may prevent inflammation-associated gut blockage.

SourceUniversity of Calgary·JournalCellular and Molecular Gastroenterology and Hepatology·TypeExperimental study·DateNov 7, 2022

Adverse pregnancy outcomes in women with inactive inflammatory bowel disease

A study by the University of Gothenburg found that women with inactive inflammatory bowel disease (IBD) have a higher risk of giving birth prematurely, particularly if they have microscopic inflammation in their intestinal mucosa. This association was not seen for other adverse pregnancy outcomes, such as growth restriction.

SourceUniversity of Gothenburg·JournalEClinicalMedicine·TypeData/statistical analysis·DateNov 7, 2022

Control hub for skin inflammation discovered

Researchers at the University of Bonn have identified a new signaling pathway that triggers inflammatory responses in the skin after UV damage. This pathway involves the activation of p38 molecularly modifying NLRP1, a critical switch for inflammation, and initiates the assembly of inflammasomes.

SourceUniversity of Bonn·JournalJournal of Experimental Medicine·DateNov 2, 2022

Plant-based diet leads to greater reduction in harmful dietary advanced glycation end-products than diet with meat and dairy

A plant-based diet significantly reduced advanced glycation end-products (AGEs) by 79%, associated with weight loss and improved insulin sensitivity. The reduction in AGEs was largely attributed to decreased meat and dairy consumption, leading to a 14-pound weight loss.

SourcePhysicians Committee for Responsible Medicine·JournalObesity Science & Practice·TypeRandomized controlled/clinical trial·DateOct 24, 2022

Mount Sinai study uncovers mechanisms of reactive oxygen species in stem cell function and inflammation prevention

The study found that a combination of NOX1, loss of function, and TNF leads to an abnormal increase in microfold cells, driving increased recruitment of immune cells. Reversing the defect with reactive oxygen species restored healthy gut balance. Further studies on reactive oxygen species-stem cell modulation therapy are proposed.

Gut bacteria may contribute to susceptibility to HIV infection, UCLA-led research suggests

Researchers found pre-existing differences in gut bacteria between people with and without HIV, including decreased Bacteroides species and increased Megasphaera elsdenii. These changes were present even before infection occurred, suggesting a potential link between gut microbiome and HIV susceptibility.

SourceUniversity of California - Los Angeles Health Sciences·JournalEBioMedicine·TypeRandomized controlled/clinical trial·DateSep 29, 2022